Jerlene Xie never thought that signing up for the Bone Marrow Donor Programme would result in a call from the registry five years later saying she was a match for an elderly man with leukaemia. She ...

Many of us will have had a tooth pulled in the dentist chair, either under local or general anesthetic, and even with modern ...

Researchers successfully tested the safety and preliminary efficacy of stem-cell-derived corneal implants, showing promise ...

A large cross-sectional study revealed that late-onset axial spondyloarthritis diagnosed after 45 years of age may represent a distinct phenotype from early-onset axial spondyloarthritis.

We also investigated correlations between levels of potential markers, histopathology according to the modified Marsh scale, and CD risk gradient based on HLA type, using Spearman rank correlation.

Life was good for Betsy Ehrenberg. It was 2017, and she was 68, a partner at Boston law firm Pyle Rome Ehrenberg PC. She represented unions in collective bargaining matters and workers who’d ...

Cellenkos® Inc., a clinical-stage biotechnology company focused on developing allogeneic, off-the-shelf, T regulatory (Treg) cell therapies for inflammatory disease areas of high unmet needs and ...

Immunocore reports third quarter financial results and provides a business updateKIMMTRAK® (tebentafusp-tebn) net revenues of $80.2 million in 3Q ...

Two poster presentations to feature novel data from the Phase 1/2 SIDNEY trial of EO2463 in indolent Non-Hodgkin Lymphoma (iNHL), highlighting initial data from Cohort 2 as monotherapy in a “watch-and ...